Shield Thera Share News (STX)

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Thursday.

----------

AIM - WINNERS

----------

Genedrive PLC, up 34% at 33.47 pence, 12-month range 8p-42p. The molecular diagnostics company says the UK's National Institute for Health & Care Excellence has preliminarily recommended its antiobiotic-induced hearing loss test for use in the National Health Service. NICE's final guidance will follow a public consultation period, which will close on February 21. "We encourage relevant stakeholders to participate during the public consultation period to support our pioneering work, and look forward to receiving the final NICE report," says CEO David Budd.

----------

Shield Therapeutics PLC, up 12% at 6.9p, 12-month range 5.5p-36p. The commercial stage pharmaceutical company updates on its annual performance, and now expects revenue of GBP8.5 million, multiplied year-on-year from GBP1.5 million. Says the period was a "landmark" year for Accrufer, its novel oral iron therapy. CEO Greg Madison notes its sales collobration with Viatris is "off to a great start".

----------

AIM - LOSERS

----------

Zytronic PLC, down 11% at 134p, 12-month range 110p-192.49p. The touch sensors manufacturer says the performance in the first four months of its financial year has been hit by ongoing global supply chain issues, leading to a shortage of some electronic components. Consequently, it has needed to buy some of these at a higher price on the "grey market", or cannibalise its existing stock. Also notes potential rising costs from proposed increases to national minimum wage and nation living wage in the UK, as well as wage negotiations with its employee representatives. It now expects revenue to be more weighted towards the second half than in the previous year.

----------

Beowulf Mining PLC, down 8.0% at 3p, 12-month range 2.38p-22.2p. The mining company launches a retail offer of up to 104.0 million new shares at 2.06p, which is around a 31% discount to its closing price on Wednesday. It plans to raise around GBP2.1 million in gross proceeds, which it will put towards its workstreams. Also conducts a preferential rights issue of up to 316.7 million Swedish depositary receipts to raise around GBP6.8 million.

----------

By Elizabeth Winter, Alliance News senior markets reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.